- 专利标题： Chimeric endolysin polypeptide
-
申请号： US18334461申请日： 2023-06-14
-
公开(公告)号： US20240148840A1公开(公告)日： 2024-05-09
- 发明人: Fritz Eichenseher , Mathias Schmelcher , Christian Alexander Rohrig
- 申请人： Micreos Human Health B.V.
- 申请人地址： NL Den Haag
- 专利权人： Micreos Human Health B.V.
- 当前专利权人： Micreos Human Health B.V.
- 当前专利权人地址： NL Den Haag
- 优先权： EP 170432.7 2020.04.20
- 分案原申请号： US17919762 2022.10.19
- 主分类号： A61K38/46
- IPC分类号： A61K38/46 ; A61P31/04
摘要：
The invention relates to the field of medicine, specifically to the field of treatment of conditions associated with Staphylococcus infection. The invention relates to a novel endolysin polypeptide specifically targeting a bacterial Staphylococcus cell. The invention further relates to said endolysin polypeptide for medical use, preferably for treating an individual suffering from a condition associated with Staphylococcus infection.
信息查询
IPC分类:
